Biogen enters ophthalmology gene therapy field with Nightstar takeover
Roche becomes a major gene therapy player with the acquisition of Spark Therapeutics
Targetgin Nr4a transcription factors a possible strategies for combatting CAR-T cell exhaustion in solid tumour treatment
Second patient HIV free after stem cell transplant: renewed interest in gene therapies targeting CCR5?
Gilead and MaxCyte expand CAR-T partnership
Orchard presents encouraging follow up data of trial of stem cell gene therapy for ADA-SCID
Autolus partners with software company Veneti to make production and delivery of CAR-T cell therapies more efficient
BioPharm partners with Trinity College Dublin to develop cell-based cancer treatments
CRISPR-Cas9 genome editing - molecular scissors a bit too sharp?
Grégoire Cullot received the ESGCT-sponsored prize for best oral presentation at the Société Française de Thérapie Cellulaire et Génique (SFTCG) Thematic Day on Viral Vectors, which took place on 17 May 2019 in Paris. Read about his winning presentation here!
Dgkk as a new therapeutic target in the Fmr1-KO murine model of Fragile X
Karima Habbas received the ESGCT-sponsored prize for best poster at the Société Française de Thérapie Cellulaire et Génique (SFTCG) Thematic Day on Viral Vectors, which took place on 17 May 2019 in Paris. Read about her winning presentation here!
Hellenic Society of Gene Therapy and Regenerative Medicine - 4th Congress
Spring School 2019 Report
Copyright ©2016 European Society of Gene and Cell Therapy | Website by OFEC